Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors

for
Breast Neoplasms, Breast Cancer
Location: Quebec city
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 18+

Code: NCT05887102

Recruiting

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06184321

Early Phase 1, Recruiting

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms

for
Cancer, Myeloid Neoplasm
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT04981821

Recruiting

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

for
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT01174121

Phase 2, Recruiting

Intra- and Inter-fraction Changes in Radiation Therapy

for
Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0+

Code: NCT02344121

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04521764

Phase 1, Recruiting

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

for
Lymphedema, Lymphedema Arm, Lymphedema of Upper Arm,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18 - 70+

Code: NCT06144164

Phase 3, Recruiting

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

for
Neoplasms, Healthy
Location: New York NY, Syracuse NY
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07258836

Phase 1, Recruiting

A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population

for
Breast Cancer
Location: Houston TX
Sponsor: Rose Imaging Specialists, P.A.

Sex: Female

Age: 30+

Code: NCT01569802

Recruiting

Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study

for
Metastatic Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT04579484

Recruiting

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06723041

Recruiting

Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction

for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06153836

Phase 2, Recruiting

HER2-PET Imaging in HER2-low Breast Cancers

for
Breast Cancer Metastatic
Location: Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sex: All

Age: 18+

Code: NCT06732336

Phase 1, Phase 2, Recruiting

Mindful Waiting Room

for
Anxiety State, Depressive State, Pain, Nausea, Fatigue, Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05433636

Recruiting

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

for
Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04510636

Phase 2, Recruiting

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

for
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer,
Location: Philadelphia PA, Memphis TN, Houston TX
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 2 - 25

Code: NCT06458036

Phase 2, Recruiting

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

for
Metastatic Breast Cancer, Unresectable Breast Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05977036

Recruiting

mychoiceTM Implementation With Medical Oncology Patients

for
Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT06222242

Recruiting

Prospective Validation of a Points Score System Predicting 30-day Survival

for
Metastatic Cancer
Location: Indianapolis IN, Carmel IN, Avon IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05100342

Recruiting

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Baltimore MD, Orlando FL, Columbus OH, Aurora CO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06233942

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial